Strides Pharma jumps on positive results for covid-19 vaccine trials
220d
00
Strides Pharma Science rallied 7.70% to Rs 336.50 after the company's subsidiary Biolexis and Akston Biosciences announced results from Phase II/III clinical trials in India for Covid-19 vaccine.